How to play a potential biotech breakout in 2025 with options
The iShares Biotechnology ETF (IBB) tracks the performance of the Nasdaq Biotechnology Index, providing exposure to U.S.-listed biotechnology and pharmaceutical companies. It is one of the most popular ETFs for investors looking to access the biotech sector, which focuses on cutting-edge advancements in medical research, drug development, and genetic engineering. In this article, I analyze […]
How to know when it’s time to take profits in your 2024 winners using charts
Several stocks have seen exceptionally strong rallies in 2024 following base breakouts in 2023. Names like Palantir (PLTR) and Applovin (APP) , which are up roughly 325% and 765% year-to-date, have “gone parabolic” post-election. In steep uptrends like theirs, it can be difficult to determine when it is appropriate to take profits, and we can […]
How to keep generating income from a tech-stock winner using options
As our Meta (META) trade from early November approaches expiration with 77% of the maximum profit captured, we are rolling the position to maintain our bullish exposure. META has now broken out above its $600 all-time highs and is forming a solid base above this level, signaling the potential for another leg higher. The stock […]
How to play this struggling tech stock for upside, while protecting for the downside
Virtually all investors aim to identify stocks that offer growth potential while being reasonably priced relative to their fundamentals. This approach is often associated with legendary investor Peter Lynch, who advocated for a balanced approach to investing. I have found an example of one such stock and how to play it with options. To characterize […]
How to buy a health care turnaround story at a discount using options
Dexcom (DXCM) , a leader in continuous glucose monitoring (CGM) systems, has positioned itself as a standout in the medical device space by leveraging innovation to maintain dominance despite rising competition. The company’s investments in digital health platforms and integration with consumer brands further solidify its competitive advantage. Investors are starting to pay attention to […]
A key U.S. inflation report looms over Wall Street. How to trade it
The October personal consumption expenditures price index report has many investors wondering how it may impact the postelection market rally. The S & P equal weight index has outperformed the market cap-weighted S & P 500 since Nov. 5. On top of that, more than 100 S & P companies hit new highs on Monday. […]
How to buy a little insurance if the 2024 market boom loses some steam into year-end
Record-breaking annual equity inflows of $448 billion, according to Bank of America, continue to push the major indices higher. The S & P 500 has now seen seven consecutive weeks of inflows, keeping the post-election momentum intact. I want to use the S & P 500 SPDR Trust ETF (SPY) to hedge these gains and […]
How to capitalize on the November dip-buying opportunity in gold
The SPDR Gold Shares (GLD) has shown remarkable strength in 2024, soaring 40% between January and October. For those who missed the rally, November offers a potential opportunity as GLD has pulled back 8% from its all-time highs, creating a dip-buying scenario. To validate a bullish outlook on GLD, I rely on specific technical indicators […]
The inherent danger of parabolic stock moves and how to handle
People always ask me why I dislike parabolic moves. The answer is simple: When a stock rises significantly in a short period — resulting in a price chart that resembles the curve of a parabola — it goes down far faster than it can creep up, for whatever reason. Consider a parabolic move from a […]
The bullish Meta trade is paying off. How to keep exposure while limiting risk with options
As we approach the expiration of our Meta Platforms (META) trade from early October we have successfully captured 78% of the total maximum gain. Given the approaching expiration and the trade’s profitability, it’s time to roll the position. The goal is to maintain bullish exposure as we continue to see a positive outlook that continues […]